Granules India Limited has informed the Exchange regarding a press release dated January 08, 2026, titled "CIN: L24110TG1991PLC012471 / Granules India Limited: 15th Floor, Granules Tower, Botanical Garden Road, Kondapur, Hyderabad 500084, Telangana, India.Press ReleaseGranules Pharmaceuticals, Inc. Receives FDA Tentative Approval with 180-Day Exclusivity for Generic Amphetamine Extended-Release Tablets (gDYANAVEL XR)".
Granules India Limited news
Investor announcements, newest first.